

Learn about common and serious Desvenlafaxine XR side effects, how to manage them, and when to call your doctor. Includes FDA labeling data.
Every medication comes with potential side effects, and Desvenlafaxine XR is no exception. The good news is that most people tolerate it well, and many side effects improve within the first few weeks of treatment. But it's important to know what's normal, what's not, and when to call your doctor.
This guide covers the most common and serious side effects of Desvenlafaxine XR (also sold as Pristiq and Khedezla), based on FDA labeling data.
Desvenlafaxine XR is a serotonin-norepinephrine reuptake inhibitor (SNRI) approved for the treatment of major depressive disorder (MDD). It's the active metabolite of Venlafaxine (Effexor XR). For a more detailed overview, see our guide on what Desvenlafaxine XR is and how it works.
These side effects are the most frequently reported in clinical trials. They usually appear within the first 1 to 2 weeks and often improve as your body adjusts:
Most of these are dose-related, meaning they're more likely at higher doses. The recommended dose of 50 mg/day tends to have fewer side effects than higher doses.
These are less common but require immediate medical attention:
Desvenlafaxine XR carries an FDA boxed warning about the increased risk of suicidal thinking and behavior, especially in young adults under 25. This risk is highest during the first few months of treatment or when the dose changes. If you or someone you know experiences worsening depression, new or sudden changes in mood, or thoughts of self-harm, contact your doctor immediately or call 988 (Suicide and Crisis Lifeline).
This is a rare but potentially life-threatening condition that can occur when Desvenlafaxine XR is combined with other serotonergic medications. Symptoms include:
Seek emergency medical care immediately if you experience these symptoms. Learn more about drug interactions that can increase this risk.
Desvenlafaxine XR can raise blood pressure. Your doctor should monitor your blood pressure regularly, especially when starting or increasing your dose.
SNRIs can affect platelet function and increase bleeding risk, particularly if you take blood thinners like Warfarin or NSAIDs like Ibuprofen.
This is more common in older adults and can cause headache, difficulty concentrating, memory problems, confusion, and weakness. In severe cases, it can lead to seizures.
Use of Desvenlafaxine XR in late pregnancy may cause complications in the newborn. The medication is also excreted in breast milk. Talk to your doctor about the risks and benefits if you are pregnant, planning to become pregnant, or breastfeeding.
Elderly patients may be at increased risk for dizziness, orthostatic hypotension (feeling lightheaded when standing), and hyponatremia. Dose adjustments may be needed.
If you have moderate to severe kidney impairment, the maximum recommended dose is 50 mg/day. For liver impairment, the maximum dose is 100 mg/day. Your doctor will adjust your dose based on your specific situation.
Here are some general strategies to manage common Desvenlafaxine XR side effects:
Contact your doctor or seek emergency care if you experience:
Most people do well on Desvenlafaxine XR, especially at the recommended 50 mg/day dose. Side effects like nausea and dizziness are common at first but usually improve within a couple of weeks. Serious side effects are rare but important to recognize.
If you're just starting Desvenlafaxine XR, keep in touch with your doctor during the first few weeks, and don't hesitate to reach out if something doesn't feel right. If you need help finding a pharmacy with Desvenlafaxine XR in stock, try Medfinder.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.